BR112012028629B8 - Método de produzir um composto de carbonato de lantânio, e, composição farmacêutica - Google Patents
Método de produzir um composto de carbonato de lantânio, e, composição farmacêuticaInfo
- Publication number
- BR112012028629B8 BR112012028629B8 BR112012028629A BR112012028629A BR112012028629B8 BR 112012028629 B8 BR112012028629 B8 BR 112012028629B8 BR 112012028629 A BR112012028629 A BR 112012028629A BR 112012028629 A BR112012028629 A BR 112012028629A BR 112012028629 B8 BR112012028629 B8 BR 112012028629B8
- Authority
- BR
- Brazil
- Prior art keywords
- carbonate
- lantanum
- producing
- lanthanum
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
- C01F17/00—Compounds of rare earth metals
- C01F17/20—Compounds containing only rare earth metals as the metal element
- C01F17/247—Carbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/01—Particle morphology depicted by an image
- C01P2004/03—Particle morphology depicted by an image obtained by SEM
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/61—Micrometer sized, i.e. from 1-100 micrometer
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/10—Solid density
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/11—Powder tap density
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/12—Surface area
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/14—Pore volume
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/80—Compositional purity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dispersion Chemistry (AREA)
- Geology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Botany (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33388710P | 2010-05-12 | 2010-05-12 | |
| US61/333,887 | 2010-05-12 | ||
| PCT/US2011/036317 WO2011143475A1 (en) | 2010-05-12 | 2011-05-12 | Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112012028629A2 BR112012028629A2 (pt) | 2017-03-21 |
| BR112012028629B1 BR112012028629B1 (pt) | 2020-02-18 |
| BR112012028629B8 true BR112012028629B8 (pt) | 2022-10-25 |
Family
ID=44279001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012028629A BR112012028629B8 (pt) | 2010-05-12 | 2011-05-12 | Método de produzir um composto de carbonato de lantânio, e, composição farmacêutica |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US8961917B2 (enExample) |
| EP (2) | EP3848040A1 (enExample) |
| JP (4) | JP5993368B2 (enExample) |
| KR (2) | KR101940207B1 (enExample) |
| CN (1) | CN103037870B (enExample) |
| AR (2) | AR081395A1 (enExample) |
| AU (1) | AU2011252983C1 (enExample) |
| BR (1) | BR112012028629B8 (enExample) |
| CA (2) | CA3224506A1 (enExample) |
| ES (1) | ES2871021T3 (enExample) |
| IL (1) | IL222824B (enExample) |
| MX (1) | MX350075B (enExample) |
| RU (1) | RU2570007C2 (enExample) |
| TW (1) | TWI446916B (enExample) |
| WO (1) | WO2011143475A1 (enExample) |
| ZA (1) | ZA201209322B (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2570007C2 (ru) * | 2010-05-12 | 2015-12-10 | Спектрум Фармасьютикалз, Инк. | Гидроксид карбонат лантана, оксикарбонат лантана и способы их получения и применения |
| US9575059B2 (en) | 2012-06-05 | 2017-02-21 | 3M Innovative Properties Company | Lanthanum-based concentration agents for microorganisms |
| SI2861595T1 (sl) | 2012-06-13 | 2017-04-26 | Incyte Holdings Corporation | Substituirane triciklične spojine kot inhibitorji fgfr |
| LT2986610T (lt) | 2013-04-19 | 2018-04-10 | Incyte Holdings Corporation | Bicikliniai heterociklai, kaip fgfr inhibitoriai |
| CN104129810A (zh) * | 2013-05-02 | 2014-11-05 | 南京大学 | 纯单斜晶相的刺球状碳酸氧镧(La2O2CO3)三维多级结构的制备 |
| CN104592994B (zh) * | 2015-01-14 | 2018-01-02 | 惠州学院 | 一种三角枝状铕掺杂羟基碳酸镧红色荧光粉的制备方法 |
| SG10201913036RA (en) | 2015-02-20 | 2020-02-27 | Incyte Corp | Bicyclic heterocycles as fgfr inhibitors |
| MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| JP6093829B1 (ja) * | 2015-10-02 | 2017-03-08 | バイエル薬品株式会社 | ランタン化合物を含む医薬組成物 |
| CN105749892B (zh) * | 2016-05-16 | 2018-02-02 | 哈尔滨工业大学 | 一种针对水体除磷的海胆状微球碳酸氧镧吸附剂的制备方法 |
| CN109314212B (zh) * | 2016-06-24 | 2022-02-08 | 日本碍子株式会社 | 包含层状双氢氧化物的功能层及复合材料 |
| CN107188215A (zh) * | 2017-05-24 | 2017-09-22 | 中国北方稀土（集团）高科技股份有限公司 | 碳酸稀土连续沉淀生产过程中自动调节反应终点的方法 |
| AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
| RU2657755C1 (ru) * | 2017-07-10 | 2018-06-15 | Александр Александрович Кролевец | Способ получения нанокапсул солей лантаноидов в каррагинане |
| EP3736041A4 (en) | 2018-01-04 | 2021-02-24 | Asahi Kasei Kabushiki Kaisha | POROUS FORMING |
| PL3788047T3 (pl) | 2018-05-04 | 2025-04-14 | Incyte Corporation | Stałe postacie inhibitora fgfr i sposoby ich otrzymywania |
| KR20210018264A (ko) | 2018-05-04 | 2021-02-17 | 인사이트 코포레이션 | Fgfr 억제제의 염 |
| EP3719486B1 (en) * | 2018-07-13 | 2023-08-09 | Fuji Electric Co., Ltd. | Carbon dioxide gas sensor |
| EP3842575A4 (en) * | 2018-08-21 | 2022-06-01 | Towa Pharmaceutical Co., Ltd. | SPECIFIC SHAPED CRYSTAL OF A COMPOUND AND METHOD OF PRODUCTION THEREOF |
| JP2020099866A (ja) * | 2018-12-21 | 2020-07-02 | 旭化成株式会社 | 多孔性成形体 |
| RU2693176C1 (ru) * | 2018-12-28 | 2019-07-01 | Общество С Ограниченной Ответственностью "Лаборатория Инновационных Технологий" | Способ получения карбонатов редкоземельных элементов |
| CN109490464A (zh) * | 2019-01-24 | 2019-03-19 | 内蒙古医科大学 | 一种基于离子色谱技术测定稀土药物中镧元素含量的方法 |
| WO2020185532A1 (en) | 2019-03-08 | 2020-09-17 | Incyte Corporation | Methods of treating cancer with an fgfr inhibitor |
| US11591329B2 (en) | 2019-07-09 | 2023-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| WO2021067374A1 (en) | 2019-10-01 | 2021-04-08 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| CR20220169A (es) | 2019-10-14 | 2022-10-27 | Incyte Corp | Heterociclos bicíclicos como inhibidores de fgfr |
| US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| AU2020395185A1 (en) | 2019-12-04 | 2022-06-02 | Incyte Corporation | Derivatives of an FGFR inhibitor |
| JP7720840B2 (ja) | 2019-12-04 | 2025-08-08 | インサイト・コーポレイション | Ｆｇｆｒ阻害剤としての三環式複素環 |
| CN113029978A (zh) * | 2019-12-25 | 2021-06-25 | 远大生命科学(辽宁)有限公司 | 一种检测含镧试剂的磷结合能力的方法 |
| WO2021146424A1 (en) | 2020-01-15 | 2021-07-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| CN113019305B (zh) * | 2021-03-03 | 2021-10-15 | 重庆三峡学院 | 多孔碱式碳酸镧磷酸盐吸附剂的制备及其应用 |
| TW202304459A (zh) | 2021-04-12 | 2023-02-01 | 美商英塞特公司 | 包含ｆｇｆｒ抑制劑及ｎｅｃｔｉｎ－４靶向劑之組合療法 |
| CN113311100A (zh) * | 2021-05-27 | 2021-08-27 | 南京诺亚药业有限公司 | 一种碳酸镧制剂中的镧含量的测定方法 |
| EP4352060A1 (en) | 2021-06-09 | 2024-04-17 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| US11939331B2 (en) | 2021-06-09 | 2024-03-26 | Incyte Corporation | Tricyclic heterocycles as FGFR inhibitors |
| CN115487839B (zh) * | 2021-06-17 | 2024-03-26 | 中国石油化工股份有限公司 | 片状催化剂及其制备方法和应用 |
| CN116924449B (zh) * | 2022-03-29 | 2025-12-09 | 包头稀土研究院 | 碱式碳酸镧颗粒及其制备方法 |
| CN116924450B (zh) * | 2022-03-29 | 2025-09-30 | 包头稀土研究院 | 用氯化稀土料液制备碱式碳酸稀土的方法 |
| CN114749182A (zh) * | 2022-03-29 | 2022-07-15 | 中国科学院兰州化学物理研究所 | 一种用于甲烷干重整的镍-氧化镧催化剂及其制备方法 |
| JP2025521859A (ja) * | 2022-07-01 | 2025-07-10 | エイエムジーエムティー | 経口投与可能な医薬剤形および高シュウ酸尿症の治療方法におけるその使用 |
| CN116809015A (zh) * | 2023-04-03 | 2023-09-29 | 中国市政工程中南设计研究总院有限公司 | 一种粘土-碳酸镧复合材料及其制备方法和应用 |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3768989A (en) | 1968-08-19 | 1973-10-30 | N Goetzinger | Process for the preparation of a rare earth oxide polishing composition |
| US3692671A (en) | 1970-10-01 | 1972-09-19 | North American Rockwell | Rare earth ion removal from waste water |
| US3922333A (en) | 1973-06-04 | 1975-11-25 | Us Air Force | Process for preparing mullite powder and fabrication of structural bodies therefrom |
| US3922331A (en) | 1973-11-14 | 1975-11-25 | Us Interior | Preparation of microporous rare-earth oxyhalides |
| US4240048A (en) | 1978-12-15 | 1980-12-16 | E. I. Du Pont De Nemours & Co. | Nonlinear optical device |
| EP0052152B1 (de) | 1980-11-14 | 1984-01-18 | Rudolf Schanze | Für Menschen und Tiere geeignetes, Spurenelemente enthaltendes Konzentrat, ein Verfahren zu seiner Herstellung und seine Verwendung |
| US4462970A (en) | 1981-08-19 | 1984-07-31 | Hughes Aircraft Company | Process for preparation of water-free oxychloride material |
| US4497785A (en) | 1983-11-18 | 1985-02-05 | Union Oil Company Of California | Production of rare earth compounds |
| JPS60206448A (ja) | 1984-03-29 | 1985-10-18 | Nissan Motor Co Ltd | 排ガス浄化用触媒担体 |
| JPS60226414A (ja) | 1984-04-20 | 1985-11-11 | Hitachi Ltd | ランタン・アルミナ系複合酸化物の製造法 |
| JPS614529A (ja) | 1984-06-15 | 1986-01-10 | Asahi Chem Ind Co Ltd | リン酸イオンの吸着剤 |
| AU601998B2 (en) | 1985-07-11 | 1990-09-27 | Rhone-Poulenc Specialites Chimiques | Oxygenated rare earth derivatives |
| US5782792A (en) | 1986-11-21 | 1998-07-21 | Cypress Bioscience, Inc. | Method for treatment of rheumatoid arthritis |
| US4919902A (en) | 1987-09-30 | 1990-04-24 | Allied-Signal Inc. | Catalyst for treatment of exhaust gases from internal combustion engines |
| FR2623797B2 (fr) | 1987-08-05 | 1990-05-04 | Inst Francais Du Petrole | Procede de conversion du methane en hydrocarbures superieurs |
| US5234957A (en) | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
| FR2634398B1 (fr) | 1988-06-29 | 1990-09-07 | Elf Aquitaine | Procede de preparation d'un catalyseur apte a promouvoir la conversion oxydante du methane en hydrocarbures superieurs |
| GB9201857D0 (en) | 1992-01-29 | 1992-03-18 | Smithkline Beecham Plc | Novel compound |
| US5407560A (en) | 1992-03-16 | 1995-04-18 | Japan Energy Corporation | Process for manufacturing petroleum cokes and cracked oil from heavy petroleum oil |
| EP0604919A1 (en) | 1992-12-28 | 1994-07-06 | Ishihara Sangyo Kaisha, Ltd. | Deodorant |
| WO1994019286A1 (en) | 1993-02-24 | 1994-09-01 | Dudley John Mills | Treatment of swimming pool water |
| US5667775A (en) | 1993-08-11 | 1997-09-16 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
| JPH0810610A (ja) | 1994-07-05 | 1996-01-16 | Ishihara Sangyo Kaisha Ltd | リン吸着剤 |
| GB9506126D0 (en) | 1995-03-25 | 1995-05-10 | Johnson Matthey Plc | Pharmaceutical composition and method |
| US6376479B1 (en) | 1995-04-03 | 2002-04-23 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
| US20020183288A1 (en) | 1995-04-03 | 2002-12-05 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
| GB9611437D0 (en) | 1995-08-03 | 1996-08-07 | Secr Defence | Biomaterial |
| JP2843909B2 (ja) | 1996-05-27 | 1999-01-06 | 科学技術庁無機材質研究所長 | 酸化イットリウム透明焼結体の製造方法 |
| JP3081910B2 (ja) | 1997-08-07 | 2000-08-28 | 工業技術院長 | ヒ素（ｖ）イオンの除去方法 |
| GB9720061D0 (en) | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
| US5843477A (en) | 1997-09-30 | 1998-12-01 | Bayer Corporation | Lubricants for use in tabletting |
| ES2221370T3 (es) | 1998-04-03 | 2004-12-16 | Egalet A/S | Composicion de liberacion controlada. |
| US6197201B1 (en) | 1998-07-29 | 2001-03-06 | The Board Of Regents Of The University & Community College System Of Nevada | Process for removal and stabilization of arsenic and selenium from aqueous streams and slurries |
| US6312604B1 (en) | 1998-10-23 | 2001-11-06 | Zodiac Pool Care, Inc. | Lanthanide halide water treatment compositions and methods |
| ES2269218T3 (es) | 1999-12-22 | 2007-04-01 | Wisconsin Alumni Research Foundation | Formiato calcico como suplemento alimentario. |
| US6338800B1 (en) | 2000-02-22 | 2002-01-15 | Natural Chemistry, Inc. | Methods and compositions using lanthanum for removing phosphates from water |
| US6521647B2 (en) | 2000-04-04 | 2003-02-18 | Pfizer Inc. | Treatment of renal disorders |
| GB0015745D0 (en) | 2000-06-27 | 2000-08-16 | Shire Holdings Ag | Treatment of bone diseases |
| JP3407039B2 (ja) | 2000-07-10 | 2003-05-19 | 独立行政法人産業技術総合研究所 | ヒ素汚染土壌洗浄剤並びにヒ素汚染土壌安定化剤及びこれらをを用いたヒ素汚染土壌修復方法 |
| FR2811571B1 (fr) | 2000-07-11 | 2002-10-11 | Flamel Tech Sa | Composition pharmaceutique orale, permettant la liberation controlee et l'absorption prolongee d'un principe actif |
| US6403523B1 (en) | 2000-09-18 | 2002-06-11 | Union Carbide Chemicals & Plastics Technology Corporation | Catalysts for the oxidative dehydrogenation of hydrocarbons |
| FR2820134A1 (fr) | 2001-01-29 | 2002-08-02 | Rhodia Elect & Catalysis | Oxychlorure de terre rare a surface specifique elevee, ses procedes de preparation et son utilisation comme catalyseur |
| US6849609B2 (en) | 2001-04-10 | 2005-02-01 | James U. Morrison | Method and composition for controlled release acarbose formulations |
| AU2002307543B2 (en) | 2001-04-23 | 2006-04-27 | Shire International Licensing B.V. | Use of rare earth compounds for the prevention of kidney stone disease |
| CA2461682A1 (en) | 2001-09-28 | 2003-04-03 | Mcneil-Ppc, Inc. | Composite dosage forms |
| US7119120B2 (en) | 2001-12-26 | 2006-10-10 | Genzyme Corporation | Phosphate transport inhibitors |
| WO2003094933A2 (en) | 2002-05-08 | 2003-11-20 | Shire Holding Ag | Use of lanthanum for the treatment of hypercalcemia and bone metastasis |
| US20060083791A1 (en) | 2002-05-24 | 2006-04-20 | Moerck Rudi E | Rare earth metal compounds methods of making, and methods of using the same |
| US20040161474A1 (en) | 2002-05-24 | 2004-08-19 | Moerck Rudi E. | Rare earth metal compounds methods of making, and methods of using the same |
| CN100526219C (zh) * | 2002-08-14 | 2009-08-12 | 爱尔达纳米公司 | 稀土金属化合物、其制造方法及其使用方法 |
| MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
| AU2003298800B2 (en) | 2002-12-02 | 2007-11-29 | Altairnano, Inc. | Rare earth compositions and structures for removing phosphates from water |
| JP4128906B2 (ja) * | 2003-05-15 | 2008-07-30 | 三井金属鉱業株式会社 | セリウム系研摩材及びセリウム系研摩材の製造方法 |
| DK2133084T3 (en) | 2003-08-26 | 2015-04-13 | Shire Biopharmaceuticals Holdings Ireland Ltd | A pharmaceutical formulation comprising LANTHANFORBINDELSER |
| US7381428B2 (en) | 2003-08-26 | 2008-06-03 | Shire International Licensing B.V. | Stabilized lanthanum carbonate compositions |
| JP4834953B2 (ja) | 2003-10-31 | 2011-12-14 | 富士ゼロックス株式会社 | 脂肪族ポリケトン類ポリマー及び脂肪族ポリケトン類ポリマー含有組成物の製造方法 |
| US7459502B2 (en) | 2003-11-03 | 2008-12-02 | Ilypsa, Inc. | Pharmaceutical compositions comprising crosslinked polyamine polymers |
| US20050182011A1 (en) | 2003-11-13 | 2005-08-18 | Eric Olson | Inhibition of TRP channels as a treatment for cardiac hypertrophy and heart failure |
| CN1557982A (zh) | 2004-01-19 | 2004-12-29 | 太原理工大学 | 细化阻燃复合剂及其制备方法 |
| KR101072196B1 (ko) | 2004-07-27 | 2011-10-10 | 샤이어 파마세우티컬, 인크. | 란탄 하이드록시 카보네이트를 이용한 고인산증 치료 방법 |
| CA2583548A1 (en) * | 2004-10-15 | 2006-04-27 | Altairnano, Inc. | Phosphate binder with reduced pill burden |
| US20060177415A1 (en) | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
| EP1698233A1 (en) | 2005-03-01 | 2006-09-06 | Bayer HealthCare AG | Reduction of digestibility of phosphorus in animal nutrition |
| JP2009504423A (ja) | 2005-08-11 | 2009-02-05 | イノヴァライト インコーポレイテッド | 安定にパッシベートされたｉｖ族半導体ナノ粒子、並びにその製造方法及びその組成物 |
| JP2009504779A (ja) | 2005-08-17 | 2009-02-05 | アルテアナノ インコーポレイテッド | 家畜における慢性腎不全及びその他の病気の治療：組成物及び方法 |
| WO2007022466A2 (en) * | 2005-08-17 | 2007-02-22 | Altairnano, Inc. | Hyperphosphatemia in domestic animals: compositions and methods of treatment |
| US20070259052A1 (en) | 2006-05-05 | 2007-11-08 | Shire International Licensing B.V. | Assay for lanthanum hydroxycarbonate |
| CN101077338B (zh) * | 2006-05-24 | 2012-06-20 | 天津大学 | 纳米碳酸镧口腔崩解片及制备方法 |
| CN102714064B (zh) | 2009-11-06 | 2015-11-25 | 泰拉能源有限责任公司 | 核裂变行波反应堆及迁移燃料组件的系统 |
| RU2570007C2 (ru) | 2010-05-12 | 2015-12-10 | Спектрум Фармасьютикалз, Инк. | Гидроксид карбонат лантана, оксикарбонат лантана и способы их получения и применения |
-
2011
- 2011-05-12 RU RU2012146818/05A patent/RU2570007C2/ru active
- 2011-05-12 JP JP2013510310A patent/JP5993368B2/ja active Active
- 2011-05-12 TW TW100116778A patent/TWI446916B/zh active
- 2011-05-12 EP EP21159393.4A patent/EP3848040A1/en active Pending
- 2011-05-12 KR KR1020177030161A patent/KR101940207B1/ko active Active
- 2011-05-12 CA CA3224506A patent/CA3224506A1/en active Pending
- 2011-05-12 US US13/106,637 patent/US8961917B2/en active Active
- 2011-05-12 MX MX2012013065A patent/MX350075B/es active IP Right Grant
- 2011-05-12 WO PCT/US2011/036317 patent/WO2011143475A1/en not_active Ceased
- 2011-05-12 KR KR1020127032038A patent/KR101830456B1/ko active Active
- 2011-05-12 AU AU2011252983A patent/AU2011252983C1/en active Active
- 2011-05-12 EP EP11721201.9A patent/EP2568989B1/en active Active
- 2011-05-12 CN CN201180023076.0A patent/CN103037870B/zh active Active
- 2011-05-12 CA CA2798081A patent/CA2798081C/en active Active
- 2011-05-12 ES ES11721201T patent/ES2871021T3/es active Active
- 2011-05-12 BR BR112012028629A patent/BR112012028629B8/pt active IP Right Grant
- 2011-05-13 AR ARP110101656A patent/AR081395A1/es active IP Right Grant
-
2012
- 2012-11-01 IL IL222824A patent/IL222824B/en active IP Right Grant
- 2012-12-10 ZA ZA2012/09322A patent/ZA201209322B/en unknown
-
2013
- 2013-12-12 US US14/104,663 patent/US10350240B2/en active Active
-
2016
- 2016-04-07 JP JP2016077533A patent/JP6397845B2/ja active Active
-
2018
- 2018-05-22 JP JP2018097513A patent/JP6938425B2/ja active Active
-
2019
- 2019-06-06 US US16/433,318 patent/US11406663B2/en active Active
-
2020
- 2020-01-10 AR ARP200100076A patent/AR117804A2/es unknown
-
2021
- 2021-09-01 JP JP2021142223A patent/JP7280318B2/ja active Active
-
2022
- 2022-07-11 US US17/861,413 patent/US20220347210A1/en not_active Abandoned
-
2025
- 2025-06-02 US US19/225,647 patent/US20250288608A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012028629B8 (pt) | Método de produzir um composto de carbonato de lantânio, e, composição farmacêutica | |
| TR201909389T4 (tr) | Terapötik nanopartikülleri hazırlamaya yönelik proses. | |
| CR20140388A (es) | Compuestos terapeuticamente activos y sus métodos de uso | |
| IN2015DN03772A (enExample) | ||
| BR112013005820A2 (pt) | mistura agrícola compreendendo silício e processo de formação de uma mistura agrícola | |
| GB2500784A8 (en) | Lung biopsy needle | |
| EP4424408A3 (en) | Processes for preparing lithium hydroxide | |
| NZ606589A (en) | 5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide, salts and uses thereof | |
| BR112015025767A2 (pt) | composição e método para decompor polietileno | |
| BR112015022139A2 (pt) | uso de poliésteres com proteção inerente às chamas em adesivos e materiais de vedação | |
| WO2014133855A8 (en) | Tuberculosis biomarkers and uses thereof | |
| BR112014026661A2 (pt) | método in vitro para diagnóstico e vigilância do câncer | |
| TR201907136T4 (tr) | Fertigasyon bileşimi ve fertigasyona yönelik yöntem. | |
| BR112015013859A2 (pt) | corpo de carbono ferromagnético, processos para a produção de um corpo de carbono ferromagnético e de um corpo de carbono, uso de um corpo de carbono ferromagnético, e, catalisador | |
| EP2533788A4 (en) | STABLE SOLUTION | |
| BR112013001932A2 (pt) | estabilizador de solos contendo material carbonáceo e métodos para uso do mesmo | |
| MX2015015755A (es) | Derivados de perhidroquinoxalina utiles como analgesicos. | |
| AU343717S (en) | Sticking plaster used for medical purposes | |
| MX390196B (es) | Metodo para fabricar una composicion que comprende un anestesico local, un heparinoide y un regulador de ph. | |
| CL2013000601A1 (es) | Mezcla estable que comprende particulas modificadas en superficie que se obtienen por la reaccion de particulas de oxido metalico, donde dicho oxido usado es oxido de un metal con al menos un compuesto de formula i y al menos un solvente; proceso para tratar particulas; uso de particulas; y proceso de preparacion de particulas. | |
| BR112014005383B8 (pt) | complexo bis-iminopiridina de lantanídeos, sistema catalítico compreendendo o dito complexo bisiminopiridina e processo para a (co)polimerização de dienos conjugados | |
| AU343718S (en) | Sticking plaster used for medical purposes | |
| MX2012008438A (es) | Procedimientos de preparacion de dispersiones acuosas basadas en poliuretano-ureas. | |
| CL2012003645A1 (es) | Composicion farmaceutica de liberacion sostenida que comprende un compuesto derivado de metastina y un polimero de acido lactico; metodo de produccion; su uso para el tratamiento o prevencion del cancer. | |
| TR201007251A2 (tr) | Kalsiyum kanal blokörü formülasyonu. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/05/2011, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B25A | Requested transfer of rights approved |
Owner name: UNICYCIVE THERAPEUTICS, INC. (US) |